Further studies must be performed to reveal the molecular mechanisms of miR-502-3p and miR-501-3p in Aβ and p-tau mediated GABAergic and Glutaminergic synapse dysfunction in AD and other neurological diseases. This evidence concerns the gene MAPT and Alzheimer disease.